|
METTL9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.919400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.305400E-01 |
| Normal-vs-Stage2 |
8.087800E-01 |
| Normal-vs-Stage3 |
4.752200E-01 |
| Normal-vs-Stage4 |
6.642100E-02 |
| Stage1-vs-Stage2 |
7.637000E-01 |
| Stage1-vs-Stage3 |
1.559780E-01 |
| Stage1-vs-Stage4 |
7.618400E-03 |
| Stage2-vs-Stage3 |
5.153400E-01 |
| Stage2-vs-Stage4 |
1.569350E-01 |
| Stage3-vs-Stage4 |
3.979000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.695200E-01 |
| Normal-vs-AfricanAmerican |
9.956100E-02 |
| Normal-vs-Asian |
8.516400E-01 |
| Caucasian-vs-AfricanAmerican |
1.279360E-01 |
| Caucasian-vs-Asian |
8.076800E-01 |
| AfricanAmerican-vs-Asian |
7.037200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.332500E-02 |
| Normal-vs-Female |
9.739900E-03 |
| Male-vs-Female |
4.45340000000405E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.787700E-02 |
| Normal-vs-Age(41-60Yrs) |
9.934400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.239600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.753800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.643800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.174200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.610300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.503200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.813000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.458200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.559600E-01 |
| Normal-vs-Grade 2 |
1.240010E-01 |
| Normal-vs-Grade 3 |
8.233400E-01 |
| Normal-vs-Grade 4 |
2.00309999999204E-05 |
| Grade 1-vs-Grade 2 |
8.210400E-01 |
| Grade 1-vs-Grade 3 |
5.179400E-01 |
| Grade 1-vs-Grade 4 |
5.862100E-03 |
| Grade 2-vs-Grade 3 |
2.584400E-01 |
| Grade 2-vs-Grade 4 |
3.86289999987355E-07 |
| Grade 3-vs-Grade 4 |
1.443720E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.46280000124355E-08 |
| Normal-vs-ccB subtype |
1.402820E-03 |
| ccA subtype-vs-ccB subtype |
3.2639446700955E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.617400E-01 |
| Normal-vs-N1 |
1.797600E-01 |
| N0-vs-N1 |
1.133230E-01 |
|
|
